InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
10
T+90 hit rate
60%
T+90 mean return
+15.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Bedrosian Camille L. Insider active across 4 companies, notably Ultragenyx Pharmaceutical Inc.. Cumulatively, 20 disclosures have been logged. Split: 0 buy · 10 sells. Total volume traded: €585k. Activity tracked since 6 May 2021. The latest transaction was disclosed on 31 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations20 total
5,925 sharesCommon StockSEC:0001628280-26-044712:0
12,425 shares@ US$3.467439.4% of flowCommon StockSEC:0000950170-25-049567:0
68,420 shares0Common StockSEC:0000950170-25-036712:0
5,421 shares@ US$5.535428.1% of flowCommon StockSEC:0000950170-24-132885:0
11,442 shares@ US$3.195232.5% of flowCommon StockSEC:0000950170-24-111809:0
3,000 sharesCommon StockSEC:0001104659-24-074767:0
3,400 shares0Common StockSEC:0000950170-24-071923:0
96,910 shares0Common StockSEC:0000950170-24-045693:0
58,333 shares0Common StockSEC:0000950170-23-066796:0
6,000 shares0Common StockSEC:0001209191-23-038818:0
2,663 shares0Common StockSEC:0001209191-23-016053:0
▼
2,821 shares@ US$66.620.0068% mcap23.4% of flowCommon StockSEC:0001209191-22-015802:0
▼
1,657 shares@ US$66.300.0040% mcap13.8% of flowCommon StockSEC:0001209191-22-005838:0
▼
1,657 shares@ US$66.3013.8% of flowCommon StockSEC:0001209191-22-005838
▼
359 shares@ US$81.143.5% of flowCommon StockSEC:0001209191-21-060765
▼
359 shares@ US$81.140.0010% mcap3.5% of flowCommon StockSEC:0001209191-21-060765:0
◇
2,500 shares@ US$55.000.0047% mcap16.2% of flowCommon StockSEC:0001209191-21-054542:0
◇
2,500 shares@ US$55.0016.2% of flowCommon StockSEC:0001209191-21-054542
▼
364 shares@ US$113.670.0014% mcap4.8% of flowCommon StockSEC:0001209191-21-031376:0
▼
364 shares@ US$113.674.8% of flowCommon StockSEC:0001209191-21-031376
20 of 20 declarations
About Bedrosian Camille L
Camille L Bedrosian is a director at Ultragenyx Pharmaceutical Inc.
